The Prinz lab studies organelle biogenesis and intracellular lipid trafficking and homeostasis. There are several related questions we are working to answer:
What is the mechanism and function of lipid exchange at membrane contacts sites?
How do ER-subdomains form and how do they contribute to lipid metabolism and organelle biogenesis?
How are lipid droplets and lipoproteins, such as VLDL produced, in the ER?
Professor of Internal Medicine in Humanitas University, Milan, Italy.
Dr. Randal Kaufman previously served as professor of Biological Chemistry and Internal Medicine and Howard Hughes Medical Research Institute investigator at the University of Michigan Medical School. He received his PhD in pharmacology from Stanford University, where he studied gene amplification as a mechanism by which cells become resistant to anticancer agents. He was a Helen Hay Whitney fellow with Nobel Laureate Dr.
Tom is an associate professor in the Department of Anatomy and Cell Biology at the University of Iowa Carver College of Medicine. His lab studies how cells respond to chronic endoplasmic reticulum stress and the impact of ER stress signaling on liver function.
I am a physician scientist studying autoimmune hepatitis and metabolic dysfunction-associated steatohepatitis. I am interested in the temporal-spatial patterning of liver disease to understand mechanisms of disease progression.
Saul J. Karpen, M.D., Ph.D., FAASLD, is the inaugural chief scientific officer for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, Richmond, Va., where he is a professor of internal medicine and adjunct professor in pediatric medicine at the VCU School of Medicine. He holds the Phillip B. Hylemon Endowed Chair of Medicine and Microbiology and is a pediatric hepatologist at the VCU Children's Hospital of Richmond.
Peter J. Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also the Co-director of the Texas Children's Center for Vaccine Development (CVD) and Texas Children's Hospital Endowed Chair of Tropical Pediatrics.
Dr. Brett Fortune serves as Chief Medical Officer (CMO) of the Miami Transplant Institute (MTI), a unique affiliation between Jackson Health System and UHealth – University of Miami Health System. In addition to his executive leadership role, he is an active member of the liver transplant team. Dr. Fortune is a nationally recognized transplant hepatologist with extensive experience in liver disease and transplant operations. Dr Fortune is an elected Fellow of the American Association for the Study of Liver Diseases and the American Society of Transplantation. Dr.
Chief of Hepatology and Liver Transplantation, Baylor Dallas and Fort Worth